Anti-Parkinsonism Drugs Flashcards
1
Q
parkinson is a progressive or nonprogressive disease
A
progressive
2
Q
cardinal signs of PD
A
- bradykinesia or akinesia
- tremors
- muscle rigdity
- postural imbalance
3
Q
use of dopamine
A
as a NT in the brain for normal functioning of the extrapyramidal motor system (voluntary movement, balance)
4
Q
pathophysiology of PD
A
reduction in Dopamine
5
Q
pathological hallmarks of PD
A
- reduction in DA neurons in substantia niagra pars compacta
- inclusion of lewy bodies
6
Q
NT levels in PD
A
- reduction in dopamine
- increase in ACh
7
Q
aim of drug treatment in PD
A
- give drugs that increase DA levels
- give drugs that decrease ACh levels
8
Q
anti PD drugs classification
A
-
dopamine agonists
- bromocriptine
- ropinirole
- pergolide
- pramipexole -
Ach antagonists
- benztropine -
MAO - B Inhibitors
- selegiline
- rasagiline -
COMT Inhibitors
-entacapone
- tolcapone -
sympathomimetics
- adrenaline - dopmaine precursor (L-DOPA)
9
Q
Adverse effects of L-dopa
A
LEVODOPA
- lethargy
- excessive sleepiness, euphoria
- vomitting
- orthostatic hypotension
- delirium, delusion
- on and off phenomenon
- psychosis
- athetosis
10
Q
contraindications of L-dopa
A
P^G^S^
- peptic ulcer disease
- psychosis
- glaucoma
- gout
- skin lesions
- severe cvs disease like hypotension and arrythmias
11
Q
drug interactions of L-dopa
A
- Anti-psychotics
- decrease the effect of l-dopa as they are DA-antagonits - Pyroxidine
- increases L-dopa metabolism, so decreases its effect - MAO inhibitors
- cause hypertensive effect due to increased levels of catecholamines - sympathomimetics
- decrease absorption of L-dope from GIT - anti-cholinergic drugs
- decrease absorption of L-dope from GIT
12
Q
L-dopa used in combination with
A
carbidopa
13
Q
benefits of CT with carbidopa
A
- increased half life of L-dopa
- decreased dose needed
- reduced adverse effects
14
Q
ergot derived dopamine agonists
A
- bromocriptine
- pergolide
15
Q
non-ergot derived dopamine agonists
A
- ropinirole
- pramipexole